Day: November 13, 2018

Precision BioSciences and MaxCyte Enter Into Clinical and Commercial License Agreement

Precision BioSciences is pleased to be working with MaxCyte. Read more about our clinical and commercial license agreement to use the MaxCyte electroporation system for non-viral delivery of genome...